Clinical Trial

Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This clinical trial is designed as a single-arm, two-center, open-label, prospective study. All participants are enrolled in the standard-dose unrelated umbilical cord blood transplantation group to evaluate the efficacy and safety of unrelated umbilical cord blood transplantation in treating Epstein-Barr virus-associated lymphoproliferative disease.
Trial Details
NCT Number NCT07381738
Lead Sponsor Fudan University
Collaborators: Huashan Hospital
Conditions Epstein-Barr Virus-associated Lymphoproliferative Diseases, Chronic Active Epstein-Barr Virus Infection, EBV Associated Lymphoma, Umbilical Cord Blood Transplant
Enrollment 80 participants
Start Date 2026-01-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-02